Unknown

Dataset Information

0

Extremely premature infants born at 23-25 weeks gestation are at substantial risk for pulmonary hypertension.


ABSTRACT:

Objective

Extremely low gestational age newborns (ELGANs) represent an especially vulnerable population. Herein, we aimed to determine incidence and severity of pulmonary hypertension associated with bronchopulmonary dysplasia (BPD-PH) in extremely immature ELGANs (gestational age: 230/6-256/7 weeks).

Methods

In this prospective observational cohort study, we assessed BPD-PH by means of several echocardiography markers and serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels at 3 and 12 months of chronological age. In addition, we analyzed incidence and efficacy of pharmacologic treatment for BPD-PH.

Results

At 3 months 15/34 ELGANs had echocardiographic evidence of BPD-PH, while at 12 months of age 6/34 still had PH. PH-targeted therapy consisted of sildenafil monotherapy in 11 and dual oral combination therapy (sildenafil and macitentan) in four ELGANs at 3 and 12 months.

Conclusion

44% (15/34) of ELGANs developed BPD-PH. All received PH-targeted pharmacotherapy at 3 months, leading to hemodynamic improvements at 12 months in most infants.

SUBMITTER: Sallmon H 

PROVIDER: S-EPMC9184271 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Extremely premature infants born at 23-25 weeks gestation are at substantial risk for pulmonary hypertension.

Sallmon Hannes H   Koestenberger Martin M   Avian Alexander A   Reiterer Friedrich F   Schwaberger Bernhard B   Meinel Katharina K   Cvirn Gerhard G   Kurath-Koller Stefan S   Gamillscheg Andreas A   Hansmann Georg G  

Journal of perinatology : official journal of the California Perinatal Association 20220401 6


<h4>Objective</h4>Extremely low gestational age newborns (ELGANs) represent an especially vulnerable population. Herein, we aimed to determine incidence and severity of pulmonary hypertension associated with bronchopulmonary dysplasia (BPD-PH) in extremely immature ELGANs (gestational age: 23<sup>0/6</sup>-25<sup>6/7</sup> weeks).<h4>Methods</h4>In this prospective observational cohort study, we assessed BPD-PH by means of several echocardiography markers and serum N-terminal pro-B-type natriure  ...[more]

Similar Datasets

| S-EPMC6374019 | biostudies-literature
| S-EPMC7286737 | biostudies-literature
| S-EPMC10173872 | biostudies-literature
| S-EPMC3565238 | biostudies-literature
| S-EPMC5966853 | biostudies-literature
| S-EPMC10902770 | biostudies-literature
| S-EPMC5843009 | biostudies-literature
| S-EPMC7409513 | biostudies-literature
| S-EPMC9528782 | biostudies-literature
| S-EPMC5095613 | biostudies-literature